Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis

Novartis, Brussels

Novartis, Kristiansand

Novartis, Lausanne

Novartis, Parkville

Novartis, Melbourne

Novartis, Liège

Novartis, Woolloongabba

Novartis, Aarau

Novartis, Bergen

Novartis, Bruges

Novartis, Zurich

Novartis, New York

Novartis, Pittsburgh

Novartis, Turku

Novartis, Baltimore

Novartis, Fairfax

Novartis, Tampere

Novartis, Mishawaka

Novartis, Reims

Novarits, Fargo

Novartis, North Chicago

Novartis, Peoria

Novartis Investigative Site, Omaha

Novartis, Lyon

Novartis Investigative Site, Houston

Novartis, San Antonio

Novartis, Amiens

Novartis, Denver

Novartis, Salouël

Novartis, Oulu

Novartis, Whittier

Novartis, Chula Vista

Novartis, La Mesa

Novartis, Portland

Novartis, Fall River

Novartis, Springfield

Novartis, Winston-Salem

Novartis, Adelaide

Novartis, Fitzroy

Novartis, South Brisbane

Novartis Investigative Site, Antwerp

Novartis Investigative Site, Saint Niklaas

Novartis Investigative Site, Edmonton

Novartis Investigative Site, London

Novartis Investigative Site, Oshawa

Novartis Investigative Site, Québec

Novartis, Fleury-Mérogis

Novartis Investigative Site, Berlin

Novartis Investigative Site, Coburg

Novartis Investigative Site, Lecco

Novartis Investigative Site, Lodi

Novartis Investigative Site, Milan

Novartis Investigative Site, Modena

Novartis Investigative Site, Pavia

Novartis, Tønsberg

Novartis Investigative Site, Jönköping

Novartis Investigative Site, Karlstad

Novartis Investigative Site, Skövde

Novartis Investigative Site, Stockholm

Novartis, Hull

Novartis Investigative Site, Manchester

Novartis Investigative Site, Portsmouth

Novartis, Salford

Novartis, Helsinki

Novartis, Oslo

Novartis, San Juan